In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of ...

DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by stock analysts at Canaccord Genuity Group from $89.00 to $99.00 in a research report issued to clients and investors on Monday, ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

Tandem Diabetes Care, Inc.’s TNDM third-quarter growth is backed by its impressive range of new products. The robust ...

Investment analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for shares of DexCom in a note ...

DexCom, Inc. (NASDAQ:DXCM) is a medical device company that specializes in continuous glucose monitoring (CGM) systems for diabetes management. It develops, manufactures, and sells CGM devices ...

大家好！今天来了解一种基于有机电化学晶体管（OECT）的硬币型、完全集成、微创连续血糖监测系统（OECT-CGM）。这一研究成果为糖尿病患者的血糖监测带来了新的希望和解决方案。接下来，我将从研究背景、系统设计与制备、性能测试与验证、技术优势与局限以及 ...

The Dexcom G7 is a continuous glucose monitoring (CGM) system designed to help individuals with diabetes manage their blood sugar levels more effectively. This advanced device provides real-time ...

If there's an art to making a great 1440p gaming monitor, then the Samsung Odyssey OLED G6 belongs in the Louvre. It won me over with its vivid panel capabilities and speedy 360Hz refresh rate ...